CLONING AND EXPRESSION OF MPT83 GEN FROM Mycobacterium tuberculosis LOCAL STRAIN IN E. coli  BL21 AS VACCINE CANDIDATE OF TUBERCULOSIS by Ahmad, Ahyar
CLONING AND EXPRESSION OF MPT83 GEN FROM Mycobacterium 
tuberculosis LOCAL STRAIN IN E. coli  BL21 AS VACCINE CANDIDATE 
OF TUBERCULOSIS 
Rosdiana Natzir
1
,Bau Dilam
1
, Muh. Nasrum Massi
2
, RosanaAgus
3
, and Ahyar Ahmad
4 
 
 
1. 
Biochemistry Department, Faculty of Medicine, HasanuddinUnivesity, Perintis Kemerdekaan Street Km. 10 
Tamalanrea, Makassar 90245, Indonesia 
2. 
Microbiology Department, Faculty of Medicine, HasanuddinUnivesity, Perintis Kemerdekaan Street Km. 10 
Tamalanrea, Makassar 90245, Indonesia 
 3.
 
Biology Department, Faculty of Natural Sciences, HasanuddinUnivesity, Perintis Kemerdekaan Street Km. 10 
Tamalanrea, Makassar 90245, Indonesia 
4. 
Chemistry Department, Mathematic and Natural Science Faculty, HasanuddinUnivesity, Perintis Kemerdekaan 
Street Km. 10 Tamalanrea, Makassar 90245, Indonesia 
 
Email: ahyarahmad@gmail.com 
 
 
ABSTRACT 
The appearance of Mycobacterium tuberculosis strains leading to drug resistance has caused new problems in TB 
treatment in various parts of the world and forces WHO to declare TB as a global emergency. With the increase of 
TB drug resistance, it is convinced that a more effective vaccine development will stop or decrease the epidemic of 
TB. Some M. tuberculosis antigens, one of which is MPT8, have been examined as TB vaccine candidate, using 
DNA recombinant technology. MPT83 antigen, which is very immunogenic in lipoprotein micro bacteria, is 
identified as surface cell interrelated to antigen with electron microscope and cytometry circulation. MPT83 can also 
stimulate humoural as well as T-cell immune response. Next, MPT83 is an M. tuberculosis surface antigen that can 
induct CD4 lymphocyte T in order to produce Interleukin-2 that has a central role in triggering immune against TB. 
Having TB resistance from BCG vaccine, MPT83 is considered TB vaccine candidate that can protect people 
against TB at adult age. The purpose of the research is to conduct amplification of MPT83 antigen cloning, and 
expression of its antigen on E coli bacteria. From the result of the research, it is expected that raw material to 
produce TB vaccine as well as a high-quality antigen can be obtained. The band  of DNA in PCR product is 660 bp, 
while the one in pGEMT-Easy-MPT83 recombinant plasmid is 3678 bp. This is expressed in BL21 E coli strain and 
produces 44 kDa protein as well as GST-MPT83 fusion protein. 
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1. Introduction 
 
Together with malaria and AIDS, tuberculosis (TB) is classified as the big three of main infection disease 
in the world. It causes 2 million deaths per year with 9 new cases per year. Indonesia reaches the third rank in the 
highest number of TB cases in the world, following India and China. In Indonesia, 70% TB occur in productive age. 
This leads to big social and economy problems. Every year about 8 million people infected develop into an active 
disease, 2 million of which die because of tuberculosis. Since about 10% of the world TB infection cases are found 
in Indonesia, Indonesia is considered the third rank after India and China (WHO, 2008). The reason why there are 
high numbers of TB cases in Indonesia is that a lot of Indonesians live in the optimum place of the development and 
spread of TB. Moreover, the increase of HIV cases and M. tuberculosis (MDR) multidrug resistance worsens the 
situation. Therefore, it is necessary to find out an effective and affordable vaccine as well as its quick and 
appropriate diagnosis method of development. The treatment of TB is getting difficult following the appearance of 
M. tuberculosis that is resistant to TB drugs (M. tuberculosis multi-drug resistant, MDR-TB). This strain is known 
resistant to 2 main antibiotics commonly used, i.e. isoniazid and rifampicin. Even more, it is found out that M. 
tuberculosis is resistant to other TB drugs (M. tuberculosis Extensively Drug Resistant, XDR-TB). Also, this strain 
is resistant to fluoroquinolone and injections such as kanamycin, capreomicyn or amikacin (WHO, 2012). 
 
The appearance of the above strains causes new problems in treating TB in various parts of the world and 
forces WHO to declare TB as a global emergency. With the increase of TB drug resistance, it is convinced that a 
more effective vaccine development will stop or decrease the epidemic of TB. Some criteria that should be fulfilled 
by TB vaccine are the abilities to provide better resistance than BCG, to give a quick response toward TB protection, 
to decrease the pain, and to prevent TB reactivation (Paridah and Kaufman, 2010). 
 
At this time, Bacillus Calmette-Guerin (BCG) is the only vaccine available for TB prophylaxis. The 
advantage of this vaccine is that it is quite safe and contains efficacy in order to prevent severe TB on children 
(Rodrigues et al, 1993). On some clinical experiments, BCG efficacy to prevent active TB on adults is found very 
low, and the lowest protection is found in countries with high TB cases, like China, India and Indonesia. When 
given to someone with immunologic system defiance, lack of  BCG can lead to infection (Jouanguy et al, 1996). As 
a consequence, a more effective vaccine development is needed so that it can provide protection towards active TB 
on adults. 
 
In connection to this, a research on the production of MPT83 antigen is conducted using DNA recombinant 
technology. At first, the production of antigen is carried out by cloning the gene encoding MPT83 recombinant 
antigen. This gene expression is conducted in vivo in bacteria, followed by quality and quantity tests on the antigen 
gained. Purification has to be done on the last phase to ensure that MPT83 antigen can be used as vaccine. The 
production of the antigen can, therefore, reduce the production cost of TB vaccine, provide protection towards active 
TB on adults, and finally, reduce the number of morbidity and mortality caused by TB. 
 
2. Materials and Methods 
 
Genomic DNA Isolation and PCR 
Blood sample as source local strain of Mycobacterium tuberculosis was collected from the pulmonary 
tuberculosis patient from the Wahidin Sudirohusodo Hospital, Makassar, Indonesia. Genomic DNA was isolated 
from Mycobacterium tuberculosis using the phenol, chloroform, and isoamyl alcohol (25:24:1) extraction method. 
In order to amplify the specific gene of our interest antigen Mpt83 product, PCR was performed using the following 
conditions: complete denaturation: 94°C for 3 min; Annealing: 55°C for 30 sec; Extension: 72°C for 1 min, 
followed by 25 cycles of amplification and the final elongation step (72°C for 7 min) using Forward Primer: 5
' 
CGAAGCTAGCATGATCAACGTTCAGGCCAA 3') and Reverse Primer:  (5' 
GCGCAAGCTTTTACTGTGCCGGGGGCATCA 3'). PCR products were separated and analyzed on 1 % agarose 
gel electrophoresis. 
 
Cloning of antigen Mpt83 gene 
The PCR product of antigen Mpt83 gene was eluted from the gel and cloned in vector pGEM-T Easy 
(Promega, USA) as per manufacturer’s instructions to yield recombinant plasmid pGEM-T Easy-Mpt83. The 
ligated mix was then transformed into competent E. coliJM109 cells, by CaCl2 method. The transformants were 
plated on Luria broth (LB) agar supplemented with Ampicillin (100g/mL), in addition with IPTG (40g/mL), and 
X-gal (20g/mL). Cells were incubated at 37º C for overnight. Blue–White screening colony selection method was 
performed to choose the white colored recombinant clone and followed by colony PCR amplification was performed 
for confirmation of cloning of our gene of interest (antigen Mpt83 gene). 
 
Plasmid Isolation 
The plasmid was isolated from positive clones by alkali-lysis method described by Sambrook et al. Briefly, 
2mL of overnight culture was centrifuged. The cell pellet was resuspended in 200μL ice cold lysis solution 1 (which 
consist of 15% glucose, 25mM Tris, 10mM EDTA) and followed by vortexed gently. Then added 400 μL of freshly 
prepared solution 2 (which consist of 0.2N NaOH, 1% SDS) and 50 μl solution 3 (3M Sodium acetate). 
Centrifugation was done at 10,000 rpm for 10 minutes and to the supernatant equal volume of iso-propanol was 
added and incubated at room temperature for 15 min. Then centrifuged at 10000 rpm for 10 min, removed the 
supernatant and pellet was washing with 70% ethanol, dried and dissolved in 50μL TE buffer for further use. 
 
Confirmation of clone by plasmid isolation and restriction digestion 
The recombinant white colonies were isolated from the LB- Ampicillin agar plates and inoculated in LB 
Ampicillin containing broth and incubated at 37°C for overnight. Plasmid DNA was isolated by Alkaline-lysis 
method. The purified plasmid was subjected to restriction digestion using NheI and HindIII. The release of the gene 
product was checked on 1% agarose gel electrophoresis. 
 
Expression and purification of GST-Mpt83 and 6xHis-tagged Mpt83 fusion proteins 
 
The Mpt83 gene of pGEM-T Easy-Mpt83 recombinant plasmid was then sub cloned into pGEX-
2TKexpression vector, respectively, resulting pGEX-2TK-Mpt83 plasmid. E. coli BL-21 cells were transformed 
with pGEX-2TK-Mpt83, harboring the GST-Mpt83 cDNAs and grown to A600 nm = 0.2 in 400 mL of LB medium 
supplemented with 200 μg/mL ampicillin. Upon induction with 50 μM  IPTG overnight at 20 °C, the cells were 
collected by centrifugation and suspended in 10 mL of lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM 
EDTA) containing 0.1% (v/v) phenylbenzosulfonyl fluoride and 1 μg/mL lysozyme, in liquid N2 for 2 min, 
followed by ultrasonication for 3 min. Continuously, the GST fusion proteins were purification with glutathione-
agarose beads essentially as described (Ahmad, et al, 1999). 
 
Data analysis 
The data obtained from the reading of the two methods were used for a comparison study. Data analysis 
from SDS-PAGE and DNA sequencing, and later analyzed using v.7.0.9 Bioedit application. The result of data 
analysis is presented in tables or figures, as well as described. 
 
3. Results  
 
Genomic DNA isolation and quantification 
The blood sample was incubated in LJ medium for 2-3 weeks. The small colonies developed in the plate, 
based on the colony morphology six bacteria were transferred in to LJ broth and used for genomic DNA isolation. 
The Mycobacteriumtuberculosis was cultured in the LJ broth media and genomic DNA was isolated by modified 
CTAB method. The isolated DNA was electrophorized in 1% Agarose gel (Figure1). The quantity and quality of 
DNA was analyzed by UV visible spectrophotometer (Shimadzu, Japan). The A260/280 value of genomic DNA 
samples showing the purity of the isolated DNA. The purity of DNA was indicated by A260/A280 ratio, where the 
value from 1.8 to 2.0 was considered as high purity. Nevertheless, the extracted DNA is considered of adequate 
purity if A260/A280 is> 1.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.Gemonic DNA isolated from H37Rv strain as positive control (1), clinical samples from local strains 
(2-7) of Mycobacterium tuberculosis,and negative control (8). 
 
 
Optimalization of PCR condition and cloning of antigen Mpt83 gene 
 
The initial stage of this research, i.e. optimizing PCR products, is to identify the range of the optimum 
temperature of PCR machine in order to get a high density DNA amplification result. The optimum condition gained 
was on primary concentration of 40 mol and 58.1C on annealing phase, and the result can be seen in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  A.PCR result of positive control Isolate (H37RV) and its clinical samples from local strains (S1 and 
S2),   B. Purification result of DNA positive control and its clinical samples (S1 and S2) from panel 
A. 
After purified, the formed DNA band was put into pGEM-T Easy plasmid vector ligation process in order 
to produce pGEM-T Easy-MPT83 recombinant vector. The ligation between plasmid and PCR product was very 
carefully carried out in an uncontaminated and sterile place, so that the fusion between plasmid vector and the 
product purified using T4 DNA Ligase enzyme can be reached with a quite low contamination level. This was then 
incubated for a night at the temperature of 4C and was ready to be transformed into JM109 E coli competent cell. 
Finally, a growth pattern of recombinant bacteria colony was obtained, as seen in Figure 3. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. E. coli growth pattern in LB-Amp Plate containing pGEM-T Easy-MPT83 recombinant plasmid 
 
  Seven white colonies of the recombinant plasmid isolation from the bacteria growing in a plate LB media 
in Figure 2 was picked up and cultured in a liquid LB media (Figure 4). After isolated using mini prep purification, 
the result of plasmid isolation encoding MPT83 antigen from Mycobacterium tuberculosis was successfully done 
towards six colonies. Meanwhile, the third colony did not grow. The result of recombinant DNA of the six colonies 
was tested using agarosa gel on electrophoresis and soon data were gained, as shown in Figure 5. 
 
  
 
 
 
 
Figure 4.Bacteria recombinant cultures in several liquid LB media 
 
 
 
 
 
 
 
 
 
Figure 5.Electrophoresis result of recombinant plasmidpGEM-T Easy-MPT83(P1-P6) 
pGEM-T Easy MPT83 recombinant plasmid was successfully reconstructed. This was shown by the 
existence of 3678bp band which was the result of insertion of  MPT83 gene into pGEM-T Easy gene. Next, pGEM-
T Easy-MPT83 was sequenced and the result can be seen in Figure 6.    
1     ATG ATC AAC GTT CAG GCC AAA CCG GCC GCA GCA GCG AGC CTC GCA   45 
1     Met Ile Asn Val Gln Ala Lys Pro Ala Ala Ala Ala Ser Leu Ala   15 
 
46    GCC ATC GTG ATT GCG TTC TTA GCG GGT TGT TCG AGC TCC AAA CCC   90 
16    Ala Ile Val Ile Ala Phe Leu Ala Gly Cys Ser Ser Ser Lys Pro   30 
 
91    GTG TCG CAA GAC ACC AGA CCG AAA CCG GCG ACC AGC CCG GCG GCG   135 
31    Val Ser Gln Asp Thr Arg Pro Lys Pro Ala Thr Ser Pro Ala Ala   45 
 
136   CCC GTT ACC ACG GCG GCA ATG GCT GAC CCC GCA GCG GAC CTG ATT   180 
46    Pro Val Thr Thr Ala Ala Met Ala Asp Pro Ala Ala Asp Leu Ile   60 
 
181   GGT CGT GGG TGC GCG CAA TAC GCG GCG CAA AAT CCC ACC GGT CCC   225 
61    Gly Arg Gly Cys Ala Gln Tyr Ala Ala Gln Asn Pro Thr Gly Pro   75 
 
226   GGA TCG GTG GCC GGA ATG GCG CAA GAC CCG GTC GCT ACC GCG GCT   270 
76    Gly Ser Val Ala Gly Met Ala Gln Asp Pro Val Ala Thr Ala Ala   90 
 
271   TCC AAC AAC CCG ATG CTC AGT ACC CTG ACC TCG GCT CTG TCG GGC   315 
91    Ser Asn Asn Pro Met Leu Ser Thr Leu Thr Ser Ala Leu Ser Gly   105 
 
316   AAG CTG AAC CCG GAT GTG AAT CTG GTC GAC ACC CTC AAC GGC GGC   360 
106   Lys Leu Asn Pro Asp Val Asn Leu Val Asp Thr Leu Asn Gly Gly   120 
 
361   GAG TAC ACC GTT TTC GCC CCC ACC AAC GCC GCA TTC GAC AAG CTG   405 
121   Glu Tyr Thr Val Phe Ala Pro Thr Asn Ala Ala Phe Asp Lys Leu   135 
 
 
406   CCG GCG GCC ACT ATC GAT CAA CTC AAG ACT GAC GCC AAG CTG CTC   450 
136   Pro Ala Ala Thr Ile Asp Gln Leu Lys Thr Asp Ala Lys Leu Leu   150 
 
451   AGC AGC ATC CTG ACC TAC CAC GTG ATA GCC GGC CAG GCG AGT CCG   495 
151   Ser Ser Ile Leu Thr Tyr His Val Ile Ala Gly Gln Ala Ser Pro   165 
 
496   AGC AGG ATC GAC GGC ACC CAT CAG ACC CTG CAA GGT GCC GAC CTG   540 
166   Ser Arg Ile Asp Gly Thr His Gln Thr Leu Gln Gly Ala Asp Leu   180 
 
541   ACG GTG ATA GGC GCC CGC GAC GAC CTC ATG GTC AAC AAC GCC GGT   585 
181   Thr Val Ile Gly Ala Arg Asp Asp Leu Met Val Asn Asn Ala Gly   195 
 
586   TTG GTA TGT GGC GGA GTT CAC ACC GCC AAC GCG ACG GTG TAC ATT   630 
196   Leu Val Cys Gly Gly Val His Thr Ala Asn Ala Thr Val Tyr Ile   210 
 
 631   ATT GAT ACG GTG CTG ATG CCC CCG CAG TAA   660 
 211   Ile Asp Thr Val Leu Met Pro Pro Gln End   220 
 
Figure 6. Predicted nucleotide and amino acid sequences of  MPT83 gen 
 
  MPT83 gene of pGEM-T Easy-MPT83 recombinant plasmid was then sub cloned into pGEX-2TK 
expression vector, resulting pGEX-2TK-MPT83 plasmid. The above expression vector was expressed into E.coli 
BL-21 bacteria as GST-MPT83 fusion protein and purified using Gluthation Agarose matrix. As shown in Figure 7, 
the result analysis of SDS-PAGE was GST protein band of 26 kDa, while the GST-MPT83 fusion protein molecule 
was 44 kDa. As a result, the size of MPT83 was 18 kDa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.Analysis pattern ofSDS-PAGE (12%) from expression of MPT83 recombinant protein in E coli 
strain BL21.  Column 1, protein marker; column 2, Total protein rough extract from E.coli containing 
pGEX-2TK MPT83 cDNA with IPTG induction; column 3, Total protein rough extract from E.colicontaining 
pGEX-2TK MPT83 cDNA without IPTG induction; column 4, GST recombinant protein complex prior to 
elution from gluthation-agarose matrices; column 5, GST recombinant protein complex prior to elution from 
gluthation-agarose matrix; column 6, GST recombinant protein complex subsequent  to elution from 
gluthation-agarose matrix; column 7, GST recombinant protein complex subsequent  to elution from 
Gluthation-agarose matrices. 
 
 
 
4. DISCUSSION 
 
The optimization phase of PCR product was carried out to learn about the range of the optimum 
temperature of PCR machine in order to get a high density DNA amplification result. PCR cycle was arranged 
during the annealing phase in order to get a certain result with high density level. By doing PCR gradient on product 
result of Positive Control (H37RV) and considering product concentration, the result gained on 40 mol and 
temperature of 58.1
o
C at annealing phase showed a thick band. Next was to amplify the DNA on positive sample 
(H37RV) and clinical sample by using PCR and to analyze them using electrophoresis method. 
 
After electrophoresis had been done and after detected using agarosa gene on Geldoc (Biohazard), the band 
on positive control (H37RV) was found much thicker than the one on clinical sample (S1 and S2) with 663 bp. This 
meant that the thicker the band formed, the higher the cloning phase possibility. Finally, purification phase of DNA 
product using KIT purification was carried out. 
 
In order to get a very pure band, purification using KIT (Qiagen) wass conducted. In this phase, it was 
learned that the band on positive control (H37RV) was very thick, while the ones in clinical samples (S1) and (S2) 
were thin and very thin. The thicker the band formed, the higher the density level, and the more suitable it was to 
move to the next level. The band formation was proceeded with the ligation process between pGEM-T Easy plasmid 
vector and purified DNA product. 
 
The ligation between plasmid and PCR product was very carefully carried out in an uncontaminated and 
sterile place, so that the fusion between plasmid vector and the product purified using T4 DNA Ligase enzyme could 
be reached with a quite low contamination level. This was then incubated for a night at the temperature of 4
o
C and 
was ready to be transformed into JM109 E coli competent cell.  
 
The transformation on the competent cell was done by creating lysis on the cell wall of E coli JM109. By 
doing so, the result of recombinant plasmid ligation could be inserted into the bacteria cell without killing it. Next, 
the recombinant bacteria was bred on a selective breeding media, i.e. solid LB medium, in order to multiply the 
recombinant bacteria as well as to learn whether the recombinant bacteria had been inserted by pGEM-T-Easy-
MPT83 recombinant plasmid or not. And, for this reason, the solid LB media was given IPTG and X-Gal, in which 
the result would show blue and white colonies. The bacteria colony inserted by recombinant plasmid would show 
white color, while the one without recombinant plasmid would show blue color. Next, the white colony formed 
would isolate the recombinant plasmid using Miniprep Kit Purification. 
 
The purpose of isolating recombinant plasmid using Miniprep Kit Purification was to obtain a pure 
recombinant plasmid, so that the DNA needed was really pure. By adding IPTG and X-Gal, pGEM-T Easy-MPT83 
recombinant plasmid was found in 5 white colonies chosen from the breeding of recombinant bacteria. The 5 white 
colonies were bred in a liquid LB media. After isolated using miniprep kit purification, a product of plasmid 
isolation encoding MPT83 antigen from Mycobacterium tuberculosis were obtained,  and then furthered tested using 
agarosa gel on electrophoresis.  
 
The results gained, P1-P6, showed that the length of the band is 3678 bp. With this length, cloning of 
pGEM-T Easy-MPT83 recombinant plasmid gene was considered successfully carried out. Also, having 3015 bp 
pGEM-T plasmid size and 663 MPT83 antigen size, it was concluded that pGEM-T Easy plasmid and MPT83 
antigen were already fused. Therefore, this product of recombinant plasmid was ready for sequencing.The 
sequencing process of pGEM-T Easy-MPT83 plasmid was carried out using Applied ABI PRISM 310 Biosystem, 
while data analysis was using Bioedit v.7.0.9. The nucleotide order data gained were compiled and translated into 
ordered amino acid, i.e. 220 amino acid, starting with 663 bp including methionine amino acid, and 221 amino acid 
for H37RV wild type.After pGEM-T Easy-MPT83 plasmid had been cloned, protein was expressed to form a fusion 
protein, i.e. GST-MPT83 fused protein.  
 
 
 
5. CONCLUSION  
 
As conclusion of the previously decribe findings are: 
1. MPT83 antigen from local strain Mycobacterium tuberculosis bacteria has been successfully amplified using 
PCR technique, resulting 660 bp band. 
2. The cloning of MPT83 gene into pGEM-T Easy vector results in recombinant plasmid with the band size of 
3678 bp. 
3. Based on the order of amino acid encoding protein in recombinant plasmid, pGEM-T Easy-MPT83 will 
besubcloning and expressed into E coli cell in order to produce protein using 44 kDa molecules as GST-MPT83 
fusion protein. 
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